Vitiligo
Vitiligo is a chronic autoimmune disorder characterized by patches of skin losing their pigment, likely influenced by genetic and immune system factors, stress, or sun exposure, and treated with methods such as topical medications, light therapy, surgery, and cosmetics. These pigment changes can affect any skin type and body area, with spots potentially altering over time.
Health Outcomes
- Altered Skin Color
- Cosmetic Material Identification
- Enhanced Phototherapy Outcome
- Enhanced Regulatory Immune System Development
- Improved Clinical Lesion Score
- Improved Cosmetic Satisfaction
- Improved Dermatology Life Quality Index
- Improved Hyperpigmentation Index
- Improved Investigator Global Assessment Score
- Improved Repigmentation
- Improved Skin Brightness Level
- Improved Skin Disease Severity
- Improved Skin Pigmentation
- Improved Skin Repigmentation
- Improved Skin Satisfaction
- Improved Tissue Pathology
- Increased Antigen-Presenting Cell Activation
- Increased Repigmentation
- Increased Repigmentation of Trunk
- Maintained Epithelium Structure
- Maintained Remission of Skin Symptoms
- Potential Skin Effect
- Reduced Dummett Oral Pigmentation Index
- Reduced Facial Pigmentation Area
- Reduced Facial Skin Pigmentation
- Reduced Melanin Pigmentation Index
- Reduced Melanin Production
- Reduced Melanogenesis
- Reduced Melanoma Risk
- Reduced Pigment Spots
- Reduced Pigmentation
- Reduced Pigmentation Change
- Reduced Skin Lesion Area
- Reduced Topical Drug Application
- Reduced UVA-Induced Thymidine Dimer Level
- Reduced Vitiligo Area Scoring Index
- Reduced Vitiligo Extension
- Reduced Vitiligo Extent Score
- Reduced Vitiligo Severity